Class Action Lawsuit Against PACS Group - Investors with substantial losses have the opportunity to lead a securities fraud class action lawsuit against PACS Group Inc (NYSE: PACS) [1] - The class period for the lawsuit is from April 11, 2024, to November 5, 2024, with a lead plaintiff deadline of January 13, 2025 [1] - Investors are encouraged to contact the Law Offices of Howard G Smith to discuss their legal rights in this class action [1] Allegations Against PACS Group - The complaint alleges that PACS Group engaged in a scheme to submit false Medicare claims, which drove more than 100% of the company's operating and net income from 2020 to 2023 [2] - The company is accused of billing thousands of unnecessary respiratory and sensory integration therapies to Medicare [2] - PACS Group allegedly falsified documentation related to licensure and staffing [2] - As a result, the company's positive statements about its business, operations, and prospects were materially misleading and/or lacked a reasonable basis [2] Participation in the Class Action - To be a member of the class action, no action is required at this time; investors may retain counsel of their choice or remain an absent member [3] - For more information or questions about the class action, investors can contact Howard G Smith, Esquire, of the Law Offices of Howard G Smith [3]
PACS Investors Have Opportunity to Lead PACS Group, Inc. Securities Fraud Lawsuit